A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes

This study tests a new drug called SHR-3167 in people with type 2 diabetes — measuring how the body absorbs, processes, and responds to the medication. **You may be eligible if...** - You are between 18 and 59 years old - You have had a confirmed type 2 diabetes diagnosis for at least 6 months - You agree to use reliable contraception during and after the study if you are of childbearing potential **You may NOT be eligible if...** - You have type 1 diabetes - You have serious kidney, liver, or heart problems - You are pregnant or planning to become pregnant - You have recently used certain diabetes medications that could interfere with the study Talk to your doctor to see if this trial is right for you.